TABLE 2.
SL. no. | Action | Effects precipitated by AMPK activation | References |
---|---|---|---|
1 | Anti-inflammatory | Dissociates PARP-1 from BCL-6 intron additionally, increase BCL-6’s expression | Gongol et al. (2013), Cameron et al. (2016) |
2 | Anti-oxidant | Increases expression of thioredoxin | Apostolova et al. (2020) |
3 | Cardio-protective | Prevents the opening of mPTP | Driver et al. (2018) |
4 | Weight loss | Downregulation of hormone—ghrelin | Gagnon et al. (2012) |
5 | Effective in PCOS | Targets TNF-α | Kai et al. (2015) |
6 | Neuro-protective | Modulates autophagy | Wang et al. (2016), Sportelli et al. (2020) |
7 | Anti-cancer | Downregulates GF receptor levels | Lei et al. (2017) |
8 | COVID-19 | Anti-viral (inhibits multiplication, and maturation, inhibit translation of viral proteins, regulate viral protein–host protein interactions) and modulates inflammation and the immune response in COVID-19 | Sharma et al. (2020), Samuel et al. (2021) |
BCL-6: B-cell lymphoma, mPTP: mitochondrial permeability transition pore, TNF-α: tumor necrosis factor-α, GF: growth factor, PCOS: polycystic ovary syndrome, PARP-1: poly (ADP-ribose) polymerase 1.